keyword
https://read.qxmd.com/read/38604544/novel-combinatorial-autophagy-inhibition-therapy-for-triple-negative-breast-cancers
#1
JOURNAL ARTICLE
Yomna S Abd El-Aziz, Taymin du Toit-Thompson, Matthew J McKay, Mark P Molloy, Shihani Stoner, Betty McDowell, Elizabeth Moon, Loretta Sioson, Amy Sheen, Angela Chou, Anthony J Gill, Patric J Jansson, Sumit Sahni
BACKGROUND: Triple negative breast cancer (TNBC) has the worst prognosis among breast cancer subtypes. It is characterized by lack of estrogen, progesterone and human epidermal growth factor 2 receptors, and thus, have limited therapeutic options. Autophagy has been found to be correlated with poor prognosis and aggressive behaviour in TNBC. This study aimed to target autophagy in TNBC via a novel approach to inhibit TNBC progression. METHODS: Immunoblotting and confocal microscopy were carried out to examine the effect of tumor microenvironmental stressors on autophagy...
April 9, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38597491/antifungal-chemosensitization-through-induction-of-oxidative-stress-a-model-for-control-of-candidiasis-based-on-the-lippia-origanoides-essential-oil
#2
JOURNAL ARTICLE
Sandra Layse F Sarrazin, Jean-Paul Bourdineaud, José Guilherme S Maia, Rosa Helena V Mourão, Ricardo B Oliveira
In this work, evaluated the antifungal chemosensitizing effect of the Lippia origanoides essential oil (EO) through the induction of oxidative stress. The EO was obtained by hydrodistillation and analyzed by GC-MS. To evaluate the antifungal chemosensitizing effect through induction of oxidative stress, cultures of the model yeast Saccharomyces cerevisiae ∆ycf1 were exposed to sub-inhibitory concentrations of the EO, and the expression of genes known, due be overexpressed in response to oxidative and mutagenic stress was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) method...
2024: Anais da Academia Brasileira de Ciências
https://read.qxmd.com/read/38552704/tidal-expiratory-flow-limitation-during-exercise-is-unrelated-to-peripheral-hypercapnic-chemosensitivity
#3
JOURNAL ARTICLE
Leah M Mann, Jason S Chan, Sarah A Angus, Connor J Doherty, Benjamin P Thompson, Glen E Foster, Paolo B Dominelli
We sought to determine if peripheral hypercapnic chemosensitivity is related to expiratory flow limitation (EFL) during exercise. Twenty participants completed one testing day which consisted of peripheral hypercapnic chemosensitivity testing and a maximal exercise test to exhaustion. The chemosensitivity testing consisting of two breaths of 10% CO2 (O2 ~21%) repeated 5 times during seated rest and the first 2 exercise intensities during the maximal exercise test. Following chemosensitivity testing, participants continued cycling with the intensity increasing 20W every 1...
March 27, 2024: Respiratory Physiology & Neurobiology
https://read.qxmd.com/read/38552361/complex-formation-of-ml324-the-histone-demethylase-inhibitor-with-essential-metal-ions-relationship-between-solution-chemistry-and-anticancer-activity
#4
JOURNAL ARTICLE
Hilda Kovács, Tamás Jakusch, Nóra V May, Szilárd Tóth, Gergely Szakács, Éva A Enyedy
N-(3-(dimethylamino)propyl-4-(8-hydroxyquinolin-6-yl)benzamide (ML324, HL) is a potent inhibitor of the iron-containing histone demethylase KDM4, a recognized potential target of cancer therapeutics. Herein, we report the proton dissociation and complex formation processes of ML324 with essential metal ions such as Fe(II), Fe(III), Cu(II) and Zn(II) using UV-visible, fluorescence, electron paramagnetic resonance and 1 H NMR spectroscopic methods. The electrochemical behaviour of the copper and iron complexes was characterized by cyclic voltammetry and spectroelectrochemistry...
March 26, 2024: Journal of Inorganic Biochemistry
https://read.qxmd.com/read/38543034/hybrid-peptide-alkoxyamine-drugs-a-strategy-for-the-development-of-a-new-family-of-antiplasmodial-drugs
#5
JOURNAL ARTICLE
Ange W Embo-Ibouanga, Michel Nguyen, Lucie Paloque, Mathilde Coustets, Jean-Patrick Joly, Jean-Michel Augereau, Nicolas Vanthuyne, Raphaël Bikanga, Naomie Coquin, Anne Robert, Gérard Audran, Jérôme Boissier, Philippe Mellet, Françoise Benoit-Vical, Sylvain R A Marque
The emergence and spread of drug-resistant Plasmodium falciparum parasites shed a serious concern on the worldwide control of malaria, the most important tropical disease in terms of mortality and morbidity. This situation has led us to consider the use of peptide-alkoxyamine derivatives as new antiplasmodial prodrugs that could potentially be efficient in the fight against resistant malaria parasites. Indeed, the peptide tag of the prodrug has been designed to be hydrolysed by parasite digestive proteases to afford highly labile alkoxyamines drugs, which spontaneously and instantaneously homolyse into two free radicals, one of which is expected to be active against P...
March 21, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38530208/fitness-level-and-sex-related-differences-in-pulmonary-limitations-to-maximal-exercise-in-normoxia-and-hypoxia
#6
JOURNAL ARTICLE
Antoine Raberin, Giorgio Manferdelli, Forrest Schorderet, Nicolas Bourdillon, Grégoire P Millet
PURPOSE: Both maximal-intensity exercise and altitude exposure challenge the pulmonary system that may reach its maximal capacities. Expiratory flow limitation (EFL) and exercise-induced hypoxemia (EIH) are common in endurance-trained athletes. Furthermore, due to their smaller airways and lung size, women, independently of their fitness level, may be more prone to pulmonary limitations during maximal-intensity exercise; particularly when performed in hypoxic conditions. The objective of this study was to investigate the impact of sex and fitness level on pulmonary limitations during maximal exercise in normoxia and their consequences in acute hypoxia...
March 25, 2024: Medicine and Science in Sports and Exercise
https://read.qxmd.com/read/38526029/depletion-of-cpne7-sensitizes-colorectal-cancer-to-5-fluorouracil-by-downregulating-atg9b-expression
#7
JOURNAL ARTICLE
Weile Xu, Yujie Tang, Yang Yang, Changjing Wang, Chen Liu, Jianqing Zhang, Lianmei Zhao, Guiying Wang
We aimed to explore the biological function of CPNE7 and determine the impact of CPNE7 on chemotherapy resistance in colorectal cancer (CRC) patients. According to the Gene Expression Profiling Interactive Analysis database and previously published data, CPNE7 was identified as a potential oncogene in CRC. RT-qPCR and Western blotting were performed to verify the expression of CPNE7. Chi-square test was used to evaluate the associations between CPNE7 and clinical features. Cell proliferation, colony formation, cell migration and invasion, cell cycle and apoptosis were assessed to determine the effects of CPNE7...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38480668/plasma-membrane-sk2-channel-activity-regulates-migration-and-chemosensitivity-of-high-grade-serous-ovarian-cancer-cells
#8
JOURNAL ARTICLE
Olivier Romito, Aude Lemettre, Aurélie Chantôme, Ophélie Champion, Noémie Couty, Lobna Ouldamer, Nadine Hempel, Mohamed Trebak, Caroline Goupille, Marie Potier-Cartereau
No data are currently available on the functional role of small conductance Ca2+ -activated K+ channels (SKCa) in ovarian cancer. Here, we characterized the role of SK2 (KCa2.2) in ovarian cancer cell migration and chemosensitivity. Using the selective non-cell-permeant SK2 inhibitor Lei-Dab7, we identified functional SK2 channels at the plasma membrane, regulating store-operated Ca2+ entry (SOCE) in both cell lines tested (COV504 and OVCAR3). Silencing KCNN2 with short interfering RNA (siRNA), or blocking SK2 activity with Lei-Dab7, decreased cell migration...
March 13, 2024: Molecular Oncology
https://read.qxmd.com/read/38464167/dual-activity-of-minnelide-chemosensitize-basal-triple-negative-breast-cancer-stem-cells-and-reprograms-immunosuppressive-tumor-microenvironment
#9
Hasan Korkaya, Fulya Koksalar Alkan, Ahmet Caglayan, Hilmi Alkan, Elayne Benson, Yunus Gunduz, Ozge Sensoy, Serdar Durdagi, Elbrus Zarbaliyev, Gregory Dyson, Hadeel Assad, Austin Shull, Ahmed Chadli, Huidong Shi, Gurkan Ozturk
Triple negative breast cancer (TNBC) subtype is characterized with higher EMT/stemness properties and immune suppressive tumor microenvironment (TME). Women with advanced TNBC exhibit aggressive disease and have limited treatment options. Although immune suppressive TME is implicated in driving aggressive properties of basal/TNBC subtype and therapy resistance, effectively targeting it remains a challenge. Minnelide, a prodrug of triptolide currently being tested in clinical trials, has shown anti-tumorigenic activity in multiple malignancies via targeting super enhancers, Myc and anti-apoptotic pathways such as HSP70...
February 22, 2024: Research Square
https://read.qxmd.com/read/38430394/molecular-classification-reveals-the-sensitivity-of-lung-adenocarcinoma-to-radiotherapy-and-immunotherapy-multi-omics-clustering-based-on-similarity-network-fusion
#10
JOURNAL ARTICLE
Jianguo Zhang, Yangyi Li, Weijing Dai, Fang Tang, Lanqing Wang, Zhiying Wang, Siqi Li, Qian Ji, Junhong Zhang, Zhengkai Liao, Jing Yu, Yu Xu, Jun Gong, Jing Hu, Jie Li, Xiuli Guo, Fajian He, Linzhi Han, Yan Gong, Wen Ouyang, Zhihao Wang, Conghua Xie
BACKGROUND: Due to individual differences in tumors and immune systems, the response rate to immunotherapy is low in lung adenocarcinoma (LUAD) patients. Combinations with other therapeutic strategies improve the efficacy of immunotherapy in LUAD patients. Although radioimmunotherapy has been demonstrated to effectively suppress tumors, the underlying mechanisms still need to be investigated. METHODS: Total RNA from LUAD cells was sequenced before and after radiotherapy to identify differentially expressed radiation-associated genes...
March 2, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38423674/brd4-targeting-protacs-synergize-with-chemotherapeutics-against-osteosarcoma-cell-lines
#11
JOURNAL ARTICLE
Clemens Lang, Sandra Stickler, Barbara Rath, Maryana Teufelsbauer, Lukas Weigl, Martin Hohenegger, Gerhard Hamilton
BACKGROUND/AIM: Osteosarcoma at an advanced stage has a poor outcome, and novel targeted therapies are needed, especially for metastatic disease. Bromodomain inhibitors (BETi) are epigenetic modulators that broadly impair the expression of oncogenic proteins and exert antitumor effects. BETi can be combined with chemotherapeutics to increase therapeutic responses with superior effects in the form of proteolysis targeting chimeras (PROTACs) that degrade proteins of interest (POI) in multiple cycles...
March 2024: Anticancer Research
https://read.qxmd.com/read/38403573/defective-exercise-related-expiratory-muscle-recruitment-in-patients-with-phox2b-mutations-a-clue-to-neural-determinants-of-the-congenital-central-hypoventilation-syndrome
#12
JOURNAL ARTICLE
P Laveneziana, Q Fossé, M Bret, M Patout, B Dudoignon, C Llontop, C Morélot-Panzini, F Cayetanot, L Bodineau, C Straus, T Similowski
INTRODUCTION AND OBJECTIVES: The human congenital central hypoventilation syndrome (CCHS) is caused by mutations in the PHOX2B (paired-like homeobox 2B) gene. Genetically engineered PHOX2B rodents exhibit defective development of the brainstem retrotrapezoid nucleus (RTN), a carbon dioxide sensitive structure that critically controls expiratory muscle recruitment. This has been linked to a blunted exercise ventilatory response. Whether this can be extrapolated to human CCHS is unknown and represents the objective of this study...
February 24, 2024: Pulmonology
https://read.qxmd.com/read/38386926/acquired-cross-resistance-in-small-cell-lung-cancer-due-to-extrachromosomal-dna-amplification-of-myc-paralogs
#13
JOURNAL ARTICLE
Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim, Jillian F Wise, Braeden Freitas, Di Yang, Edmond Wong, Seth Hamilton, Victor D Chien, Yoon Jung Kim, Collin Gilbreath, Jun Zhong, Sarah Phat, David T Myers, Camilla L Christensen, Hanieh Mazloom-Farsibaf, Marcello Stanzione, Kwok-Kin Wong, Yin P Hung, Anna F Farago, Catherine B Meador, Nicholas J Dyson, Michael S Lawrence, Sihan Wu, Benjamin J Drapkin
Small cell lung cancer (SCLC) presents as a highly chemosensitive malignancy but acquires cross-resistance after relapse. This transformation is nearly inevitable in patients but has been difficult to capture in laboratory models. Here, we present a pre-clinical system that recapitulates acquired cross-resistance, developed from 51 patient-derived xenograft (PDX) models. Each model was tested in vivo against three clinical regimens: cisplatin plus etoposide, olaparib plus temozolomide, and topotecan. These drug-response profiles captured hallmark clinical features of SCLC, such as the emergence of treatment-refractory disease after early relapse...
February 22, 2024: Cancer Discovery
https://read.qxmd.com/read/38373050/in-vitro-chemosensitivity-testing-of-the-feline-large-granular-lymphocyte-cell-line-s87
#14
JOURNAL ARTICLE
Svenja Hartung, Christiane Herden, Marion Sparenberg, Manfred Henrich
BACKGROUND: Feline large granular lymphocyte (LGL) lymphoma is an aggressive neoplasia characterised by short survival and poor response to chemotherapy. OBJECTIVES: In this study, the effect of different chemotherapeutic agents on the growth kinetics of the feline cell line S87, a non-MHC-restricted feline LGL cell line, was investigated. Where possible, IC50 (inhibitory concentration 50) values were determined. The IC50 values of the cell line as lymphoma models can provide clues to the situation in vivo and serve as a basis for studying resistance mechanisms...
March 2024: Veterinary Medicine and Science
https://read.qxmd.com/read/38350880/tretinoin-improves-the-anti-cancer-response-to-cyclophosphamide-in-a-model-selective-manner
#15
JOURNAL ARTICLE
Caitlin M Tilsed, M Lizeth Orozco Morales, Rachael M Zemek, Brianna A Gordon, Matthew J Piggott, Anna K Nowak, Scott A Fisher, Richard A Lake, W Joost Lesterhuis
BACKGROUND: Chemotherapy is included in treatment regimens for many solid cancers, but when administered as a single agent it is rarely curative. The addition of immune checkpoint therapy to standard chemotherapy regimens has improved response rates and increased survival in some cancers. However, most patients do not respond to treatment and immune checkpoint therapy can cause severe side effects. Therefore, there is a need for alternative immunomodulatory drugs that enhance chemotherapy...
February 13, 2024: BMC Cancer
https://read.qxmd.com/read/38330928/assessment-of-intranasal-function-of-the-trigeminal-nerve-in-daily-clinical-practice
#16
REVIEW
Konstantinos Garefis, Dimitrios Markou, Angelos Chatziavramidis, Vasilios Nikolaidis, Konstantinos Markou, Iordanis Konstantinidis
BACKGROUND: The trigeminal nerve is a mixed cranial nerve responsible for the motor innervation of the masticatory muscles and the sensory innervation of the face, including the nasal cavities. Through its nasal innervation, we perceive sensations, such as cooling, tingling and burning, while the trigeminal system mediates the perception of airflow. However, the intranasal trigeminal system has received little attention in the clinical evaluation of patients with nasal pathology. SUMMARY: Testing methods that enable the clinical assessment of intranasal trigeminal function have recently been developed...
February 8, 2024: ORL; Journal for Oto-rhino-laryngology and its related Specialties
https://read.qxmd.com/read/38244464/the-potential-interaction-between-chemosensitivity-and-the-development-of-cardiovascular-disease-in-obstructive-sleep-apnea
#17
JOURNAL ARTICLE
Lu Dai, Junwei Guo, Xinjie Hui, Xiaona Wang, Jinmei Luo, Rong Huang, Yi Xiao
OBJECTIVES: Chemosensitivity is an essential part of the pathophysiological mechanisms of obstructive sleep apnea (OSA). Not only does OSA have a certain relationship with the comorbidity of cardiovascular disease (CVD) but also chemosensitivity plays a crucial role in the development of CVD. This study aims to investigate the potential interaction between chemosensitivity and the development of CVD in OSA. METHODS: A total of 169 participants with suspected OSA were included...
January 13, 2024: Sleep Medicine
https://read.qxmd.com/read/38242546/clinical-impact-of-ca-125-elimination-rate-constant-k-kelim-on-surgical-strategy-in-advanced-serous-ovarian-cancer-patients
#18
JOURNAL ARTICLE
Barnabe Bouvarel, Oliver Colomban, Jean-Sebastien Frenel, Cécile Loaec, Charlotte Bourgin, Dominique Berton, Gilles Freyer, Benoit You, Jean-Marc Classe
OBJECTIVES: The modeled CA-125 elimination constant K (KELIM) is a pragmatic early marker of tumor chemosensitivity in ovarian cancer patients treated with neoadjuvant chemotherapy before interval surgery. The primary objective of this study was to assess the prognostic value of KELIM regarding the feasibility of complete surgery, and secondary objectives were to assess the prognostic value of KELIM for the risk of a platinum resistant relapse, progression free survival, and overall survival...
January 19, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38225605/kras-is-a-molecular-determinant-of-platinum-responsiveness-in%C3%A2-glioblastoma
#19
JOURNAL ARTICLE
Candida Zuchegna, Stefano Leone, Antonella Romano, Antonio Porcellini, Samantha Messina
BACKGROUND: KRAS is the undisputed champion of oncogenes, and despite its prominent role in oncogenesis as mutated gene, KRAS mutation appears infrequent in gliomas. Nevertheless, gliomas are considered KRAS-driven cancers due to its essential role in mouse malignant gliomagenesis. Glioblastoma is the most lethal primary brain tumor, often associated with disturbed RAS signaling. For newly diagnosed GBM, the current standard therapy is alkylating agent chemotherapy combined with radiotherapy...
January 15, 2024: BMC Cancer
https://read.qxmd.com/read/38201547/oncobreast-test-is-a-quick-diagnostic-prognostic-and-predictive-method-of-response-to-systemic-treatment
#20
JOURNAL ARTICLE
Anna Tankiewicz-Kwedlo, Tomasz Lobacz, Leszek Kozlowski, Bogumila Czartoryska-Arlukowicz, Mariusz Koda, Krystyna Pawlak, Robert Czarnomysy, Magdalena Joanna Borkowska, Dariusz Pawlak
ONCOBREAST-TEST is a diagnostic and therapeutic procedure that is part of the comprehensive care of a patient with breast cancer.: Chemosensitivity of cancer cells was assessed using the MTT test, morphological assessment of cells, LDH activity in the culture medium, and flow cytometry technique (apoptosis, proliferation, CD24, CD44, GATA3, cytokeratin, Ki-67). Diagnostic tools included panels of simple tests which could be used to accurately predict the chemosensitivity of tumor cells previously isolated from a patient, even before actual chemotherapy...
December 26, 2023: Cancers
keyword
keyword
160204
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.